“Should pathologists and clinicians continue to consider Grade Group 1 (Gleason score ≤6) prostate cancer as a true carcinoma? Let’s hear from patient advocates”, Arch Ital Urol Androl, vol. 97, no. 2, Jun. 2025, doi: 10.4081/aiua.2025.13925.